Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Bonanni

Showing results (141-150 of 265) with videos related to

Pageof 27
Sort By:
Cancer Cell|April 30, 2019
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 AxisMohamed Elgendy, Marco Cirò, Amir Hosseini, et al.
NPJ Breast Cancer|March 26, 2021
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trialAndrea DeCensi, Harriet Johansson, Thomas Helland, et al.
Circulation|February 9, 2005
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trialAndrea Decensi, Patrick Maisonneuve, Nicole Rotmensz, et al.
Breast Cancer Research and Treatment|September 26, 2014
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trialAndrea DeCensi, Matteo Puntoni, Sara Gandini, et al.
Journal of the National Cancer Institute|May 2, 2007
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomyUmberto Veronesi, Patrick Maisonneuve, Nicole Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2007
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy usersAndrea Decensi, Sara Gandini, Davide Serrano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2024
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situElena Guerini-Rocco, Federica Bellerba, Alberto Concardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trialBernardo Bonanni, Matteo Puntoni, Massimiliano Cazzaniga, et al.
Plos One|September 3, 2024
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancerAliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in ItalyValentina Silvestri, Piera Rizzolo, Veronica Zelli, et al.
Pageof 27

Showing results (141-150 of 265) with videos related to

Sort By:
Pageof 27
Cancer Cell|April 30, 2019
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 AxisMohamed Elgendy, Marco Cirò, Amir Hosseini, et al.
NPJ Breast Cancer|March 26, 2021
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trialAndrea DeCensi, Harriet Johansson, Thomas Helland, et al.
Circulation|February 9, 2005
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trialAndrea Decensi, Patrick Maisonneuve, Nicole Rotmensz, et al.
Breast Cancer Research and Treatment|September 26, 2014
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trialAndrea DeCensi, Matteo Puntoni, Sara Gandini, et al.
Journal of the National Cancer Institute|May 2, 2007
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomyUmberto Veronesi, Patrick Maisonneuve, Nicole Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2007
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy usersAndrea Decensi, Sara Gandini, Davide Serrano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2024
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situElena Guerini-Rocco, Federica Bellerba, Alberto Concardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trialBernardo Bonanni, Matteo Puntoni, Massimiliano Cazzaniga, et al.
Plos One|September 3, 2024
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancerAliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in ItalyValentina Silvestri, Piera Rizzolo, Veronica Zelli, et al.
Pageof 27